إعلان
إعلان

JAGX

JAGX logo

Jaguar Health, Inc.

1.05
USD
برعاية
-0.03
-2.31%
٠٩ يناير, ١٥:٠٥ UTC -5
مفتوح

تقارير أرباح JAGX

النسبة الإيجابية المفاجئة

JAGX تفوق 13 من 30 آخر التقديرات.

43%

التقرير التالي

بيانات التقرير القادم
٣٠ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$4.30M
/
-$4.34
التغير الضمني من Q3 25 (Revenue/ EPS)
+39.32%
/
-30.89%
التغير الضمني من Q4 24 (Revenue/ EPS)
+23.96%
/
+1176.47%

Jaguar Health, Inc. earnings per share and revenue

On ١٨ نوفمبر ٢٠٢٥, JAGX reported earnings of -6.28 USD per share (EPS) for Q3 25, missing the estimate of -5.18 USD, resulting in a -21.20% surprise. Revenue reached 3.08 مليون, compared to an expected 3.80 مليون, with a -18.97% difference. The market reacted with a -8.03% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 المحللين forecast an EPS of -4.34 USD, with revenue projected to reach 4.30 مليون USD, implying an نقصان of -30.89% EPS, and زيادة of 39.32% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Pharmaceuticals Inc. Common
Report Date
٢٦ ديسمبر ٢٠٢٥ إلى ربع سنوي4 25
تقدير
-$0.49
الفعلي
-
مفاجئة
-
الأسئلة الشائعة
For Q3 2025, Jaguar Health, Inc. reported EPS of -$6.28, missing estimates by -21.2%, and revenue of $3.08M, -18.97% below expectations.
The stock price moved down -8.03%, changed from $1.80 before the earnings release to $1.66 the day after.
The next earning report is scheduled for ٣٠ مارس ٢٠٢٦.
Based on 3 المحللين, Jaguar Health, Inc. is expected to report EPS of -$4.34 and revenue of $4.30M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان